MELBOURNE, AUSTRALIA 6 OCTOBER 2020
For the first time in Australia a purpose-built Biobank will be established to store tissue samples and clinical data for research into rare genetic diseases caused by changes to genes on Chromosome 15, including Prader-Willi Syndrome (PWS) and Angelman Syndrome (AS).
Prader-Willi Research Foundation Australia (PWRFA) founder and CEO Kathlene Jones announced the project today, in partnership with Associate Professor David Godler and Professor David Amor from the Murdoch Children’s Research Institute (MCRI) and the Royal Children’s Hospital (RCH), and Meagan Cross, Chairperson of Foundation for Angelman’s Syndrome Therapeutics (FAST).
“For the first time Australia will have a purpose-built biobank of biological samples from people with genetic diseases caused by changes to genes on Chromosome 15,” Ms Jones said today.